Found 5 matching trials
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. PHASE1 The objective of this study is to assess the overall response rate, evaluat...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies PHASE3 This is an open-label, multicenter, extension study to evaluate the long-te...
Show More Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Learn More & Join Trial
A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer PHASE2 The main objective of this study was to evaluate the anti-tumor activity of...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer PHASE2 The purpose of this study is to assess the antitumor activity, safety, and ...
Show More Status
Active Not Recruiting
Location
Valkyrie Clinical Trials
Learn More & Join Trial
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors PHASE1 The purpose of this study is to assess the safety and tolerability of BGB-A...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial